🇺🇸 FDA
Patent

US 6680172

Treatments and markers for cancers of the central nervous system

expired A61PA61P35/00

Quick answer

US patent 6680172 (Treatments and markers for cancers of the central nervous system) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00